U.S. Health Care REITs Stock News

Shake Shack (SHAK) opened Q1 2026 with revenue of US$366.7 million and a small net loss of US$0.29 million, translating to basic EPS of about a US$0.01 loss. On a trailing twelve month basis, EPS stood at US$1.02 on revenue of roughly US$1.5 billion. The company’s quarterly revenue moved from US$320.9 million in Q1 2025 to US$366.7 million in Q1 2026, alongside a shift in quarterly basic EPS from US$0.11 to a slight loss. This sets up a mixed read on top line scale versus near term...

Warner Bros. Discovery (WBD) has opened 2026 with Q1 revenue of US$8.9 billion and a basic EPS loss of US$1.17, as the company continues to report negative net income. Over recent quarters, revenue has moved within a tight band from US$8.9 billion to US$10.0 billion, while basic EPS has swung between a profit of US$0.64 and a loss of US$1.17, underscoring how volatile margins have been as management works to improve the bottom line. See our full analysis for Warner Bros. Discovery. With the...

Kenvue (KVUE) opened Q1 2026 with revenue of US$3,909 million and basic EPS of US$0.25, setting the tone for a results season where profitability is firmly in focus. Over recent quarters, the company has seen revenue move from US$3,662 million in Q4 2024 to US$3,741 million in Q1 2025 and then to US$3,909 million in the latest quarter. Basic EPS progressed from US$0.15 to US$0.17 and now US$0.25. For investors, the key takeaway is how these numbers feed into a higher net profit margin and...

MarketWise (MKTW) opened 2026 with Q1 revenue of US$77.0 million and a basic EPS loss of US$0.23, compared with Q1 2025 revenue of US$83.5 million and EPS of US$0.43. This set a clear reset in the earnings run rate. Over the past year, the company has seen total revenue across reported quarters move from US$97.5 million in Q4 2024 to a range between about US$80 million and US$83 million through 2025. Quarterly EPS shifted from US$1.07 in Q4 2024 to positive figures across 2025 before slipping...

Rapport Therapeutics (RAPP) opened Q1 2026 with revenue of US$20 million, a basic EPS loss of US$0.42, and a net income loss of US$19.86 million, providing a clear snapshot of a company still in investment mode. Over the past year, the company has seen quarterly revenue move from US$0 to US$20 million, while quarterly basic EPS loss shifted between US$0.57 and US$0.75 before landing at US$0.42 in the latest quarter. This gives investors a clearer view of how top-line and per-share losses are...

EPAM Systems (EPAM) opened Q1 2026 with revenue of about US$1.4 billion and basic EPS of US$1.53, while over the trailing twelve months it recorded revenue of roughly US$5.6 billion and basic EPS of US$7.01, setting a clear snapshot of its recent scale and earnings power. Over the past reported periods, revenue has moved from US$1,301.7 million in Q1 2025 to US$1,400.1 million in Q1 2026, with quarterly basic EPS ranging between US$1.29 and US$1.99 during that stretch. This gives investors a...

Akebia Therapeutics (AKBA) opened Q1 2026 with total revenue of US$53.5 million and a basic EPS loss of US$0.03, alongside a quarterly net loss of US$9.1 million. On a trailing twelve month basis, revenue was US$232.4 million with a net loss of US$20.5 million and basic EPS of US$0.08. Over the last five reported quarters, the company has seen quarterly revenue range between US$46.5 million and US$62.5 million, with basic EPS moving from a profit of US$0.03 in Q1 2025 to losses such as...

NRG Energy (NRG) has laid out a busy start to 2026, with Q1 revenue of about US$10.3b and net income of US$108m translating into EPS of US$0.52, alongside trailing twelve month revenue of roughly US$32.4b and EPS of US$0.87. The company has seen quarterly revenue move from US$6.8b in Q4 2024 to US$8.6b in Q1 2025 and then to US$10.3b in Q1 2026, while quarterly EPS shifted from US$3.09 to US$3.70 and then to US$0.52 over the same stretch, setting a mixed backdrop for the latest print. With...

GoodRx Holdings (GDRX) has posted Q1 2026 revenue of US$194.0 million with basic EPS of about US$0.00, alongside trailing twelve month revenue of US$787.9 million and basic EPS of US$0.06. This gives investors a clear read on both the latest quarter and the broader run rate. Over the past year, the company has seen quarterly revenue move between US$194.0 million and US$203.1 million, while basic EPS has ranged from roughly US$0.00 to US$0.04, so the Q1 print slots into a period where earnings...

Arrow Electronics (ARW) opened Q1 2026 with total revenue of about US$9.5b and basic EPS of US$4.58, setting a clear marker for how its core distribution and solutions business is performing as the year gets underway. Over recent quarters the company has seen revenue move from roughly US$7.3b in Q4 2024 to US$6.8b in Q1 2025 and then up to US$9.5b in Q1 2026, while quarterly basic EPS shifted from US$1.88 to US$1.53 and then to US$4.58, giving investors a concrete read on how earnings are...

Charles River Laboratories International (CRL) opened 2026 with Q1 revenue of US$995.8 million and a basic EPS loss of US$0.30, alongside net income excluding extra items of a US$14.8 million loss, with the stock trading around US$181.68. The company has seen quarterly revenue move from US$984.2 million in Q1 2025 to just over US$1.0 billion across several recent periods, while basic EPS has swung between a profit of about US$1.11 and a much larger loss of about US$5.62. This has left margins...

Watts Water Technologies (WTS) opened 2026 with Q1 revenue of US$677.3 million and basic EPS of US$2.97, while the trailing twelve months show total revenue of US$2.56 billion and basic EPS of US$10.94, supported by net income of US$366.4 million. The company has seen quarterly revenue move from US$558 million and EPS of US$2.21 in Q1 2025 to US$677.3 million and EPS of US$2.97 in Q1 2026. The trailing net profit margin is 14.3%, compared with 13.1% a year earlier, highlighting an earnings...

BlackSky Technology (BKSY) opened 2026 with Q1 revenue of about US$20.8 million and a loss per share of roughly US$0.82, as net income excluding extra items came in at a loss of US$29.7 million against a share price of US$32.24. Over recent quarters, the company has seen revenue move between US$19.6 million and US$35.2 million while EPS ranged from a loss of about US$0.02 to US$1.27. This sets a mixed backdrop for investors who are focused on how quickly margins might eventually firm up. See...

Unity Software (U) opened Q1 2026 with revenue of US$508.2 million and a basic EPS loss of US$0.80, compared with US$435.0 million of revenue and a basic EPS loss of US$0.19 in Q1 2025, while trailing 12 month revenue sat at about US$1.9 billion and EPS at a loss of US$1.58. Over the past year, quarterly revenue has ranged from US$435.0 million to US$508.2 million and quarterly EPS losses have moved between US$0.19 and US$0.80, giving investors a clear view of the trade off between scale and...

UGI (UGI) has just posted Q2 2026 results that put the spotlight firmly on its income statement, with revenue of about US$2.7b and basic EPS of US$2.42, while trailing twelve month revenue sits at US$7.4b and EPS at US$2.98. Over the past few quarters, revenue has ranged from US$1.2b in Q4 2024 to around US$2.7b in Q2 2026, with quarterly EPS moving from a loss of US$1.27 in Q4 2024 to a gain of US$2.42 most recently, and trailing twelve month net income reaching US$641m. For investors, the...

Insulet (PODD) opened 2026 with Q1 revenue of US$761.7 million and basic EPS of US$1.30, while trailing twelve month revenue sat at about US$2.9 billion with basic EPS of US$4.31. This gives investors a clear view of both the quarterly print and the recent run rate. Over the last six reported quarters, revenue has moved from US$569 million in Q1 2025 to US$761.7 million in Q1 2026, with quarterly basic EPS ranging between US$0.32 and US$1.44 over that stretch. With trailing net profit margin...

Hudson Technologies (HDSN) has opened 2026 with Q1 revenue of US$60.2 million and basic EPS of US$0.01, alongside trailing twelve month revenue of US$251.4 million and EPS of US$0.33. Over the last year, the company has seen quarterly revenue move from US$55.3 million in Q1 2025 to US$60.2 million in Q1 2026, while basic EPS shifted from US$0.06 to US$0.01. This sets up a mixed read on earnings momentum as investors focus on how margins are holding up across the refrigerant cycle. See our...

Goodyear Tire & Rubber (GT) has just posted Q1 2026 results with revenue of US$3,881 million and a basic EPS loss of US$0.86, alongside trailing 12 month EPS of US$7.23 in losses on revenue of US$17.9 billion that keeps the business in negative territory. Over recent quarters, revenue has moved between US$4,253 million in Q1 2025 and US$4,917 million in Q4 2025 while basic EPS has swung from a profit of US$0.40 in Q1 2025 to a large loss of US$7.62 in Q3 2025 and back to a loss of US$0.86 in...

Alto Ingredients (ALTO) opened Q1 2026 with total revenue of US$224.7 million and net income of US$4.0 million, equal to basic EPS of US$0.05 for the quarter. Over the past year, the company has seen quarterly revenue move between US$218.4 million and US$240.9 million, while basic EPS has ranged from a loss of US$0.57 in Q4 2024 to a profit of US$0.29 in Q4 2025. This positions the latest results as part of a broader swing back into positive earnings. The mix of steady revenue levels and...

Warrior Met Coal has completed its Blue Creek mine ahead of schedule, marking a key operational milestone for NYSE:HCC. The project adds meaningful production capacity at a time when analyst sentiment around the company is turning more bullish. The mine completion, together with a swing to profitability, is shaping a fresh phase in Warrior Met Coal’s operating profile. For investors tracking NYSE:HCC, Blue Creek’s early completion comes on top of a very large 5 year return and a 94.8% gain...

Liquidity Services (LQDT) has just posted Q2 2026 results with revenue of US$120.7 million and basic EPS of US$0.24, set against trailing 12 month revenue of US$479.9 million and EPS of US$0.98 that were previously reported to be supported by 24.6% earnings growth over the past year. Over recent quarters, revenue has ranged between about US$116 million and US$122 million while quarterly EPS has held around US$0.19 to US$0.25. This gives investors a clearer view of how earnings and cash...

PureCycle Technologies (PCT) has opened 2026 with Q1 revenue of US$4.1 million, a basic EPS loss of US$0.19 and a net loss of US$33.4 million, setting a clear tone for how the year is starting to shape up for shareholders. The company has seen quarterly revenue move from US$1.6 million in Q1 2025 to US$4.1 million in Q1 2026, while basic EPS has swung from a profit of US$0.05 to a loss of US$0.19, so the latest print keeps margins under pressure even as the top line scales. See our full...

RXO (RXO) opened 2026 with Q1 revenue of US$1.4b and a basic EPS loss of US$0.21, alongside a trailing twelve month EPS loss of US$0.62 on revenue of US$5.7b that keeps the focus firmly on the income statement. Looking back, quarterly revenue has moved in a tight band between US$1.4b and US$1.7b since Q4 2024, while basic EPS has stayed in negative territory across each of the last six reported quarters, ranging from a loss of US$0.05 to US$0.27 per share. For investors, the headline is that...

Apellis Pharmaceuticals (APLS) opened Q1 2026 with total revenue of US$268.3 million and basic EPS of US$0.15, anchored by net income of US$18.7 million, while its trailing 12 month revenue stood at US$1.1 billion with basic EPS of US$1.05 and net income of US$133.3 million. Over recent quarters the company has seen quarterly revenue range from US$166.8 million to US$458.6 million and basic EPS swing between a loss of US$0.74 and a gain of US$1.71, which places this latest quarter within a...